Gilead Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7,330	9,991	6,085	5,412	5,338	5,997
Short-Term Investments	1,160	1,577	2,265	1,446	2,067	2,827
Cash & Short-Term Investments	8,490	11,568	8,350	6,858	7,405	8,824
Cash Growth	26.77%	38.54%	21.76%	-7.39%	-16.08%	-64.23%
Accounts Receivable	5,095	4,420	4,660	4,777	4,493	4,892
Receivables	5,095	4,420	4,660	4,777	4,493	4,892
Inventory	1,785	1,710	1,787	1,507	1,618	1,683
Prepaid Expenses	1,790	480	559	1,241	1,181	585
Other Current Assets	714	995	729	60	75	12
Total Current Assets	17,874	19,173	16,085	14,443	14,772	15,996
Property, Plant & Equipment	5,500	5,929	5,898	5,980	5,663	5,613
Long-Term Investments	2,778	327	1,819	2,611	2,844	3,820
Goodwill	8,314	8,314	8,314	8,314	8,332	8,108
Other Intangible Assets	17,970	19,948	26,454	28,894	33,455	33,126
Long-Term Deferred Tax Assets	1,998	-	-	-	-	-
Other Long-Term Assets	4,099	5,304	3,555	2,929	2,886	1,744
Total Assets	58,533	58,995	62,125	63,171	67,952	68,407
Accounts Payable	808	833	550	905	705	844
Accrued Expenses	4,931	5,120	5,003	4,497	6,996	6,390
Current Portion of Long-Term Debt	2,806	1,815	1,798	2,273	1,516	2,757
Current Portion of Leases	-	113	125	111	101	107
Current Income Taxes Payable	-	1,646	1,208	959	539	598
Other Current Liabilities	3,753	2,477	2,596	2,492	1,753	701
Total Current Liabilities	12,298	12,004	11,280	11,237	11,610	11,397
Long-Term Debt	22,135	24,896	23,189	22,957	25,179	28,645
Long-Term Leases	-	498	546	467	489	608
Long-Term Deferred Tax Liabilities	597	724	1,588	2,673	4,356	3,914
Other Long-Term Liabilities	2,047	1,627	2,773	4,628	5,254	5,622
Total Liabilities	37,077	39,749	39,376	41,962	46,888	50,186
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	8,678	7,700	6,500	5,550	4,661	3,880
Retained Earnings	12,825	11,497	16,304	15,687	16,324	14,381
Comprehensive Income & Other	36	132	28	2	83	-60
Total Common Equity	21,540	19,330	22,833	21,240	21,069	18,202
Minority Interest	-84	-84	-84	-31	-5	19
Shareholders' Equity	21,456	19,246	22,749	21,209	21,064	18,221
Total Liabilities & Equity	58,533	58,995	62,125	63,171	67,952	68,407
Total Debt	24,941	27,322	25,658	25,808	27,285	32,117
Net Cash (Debt)	-14,446	-15,754	-16,145	-17,705	-18,571	-22,791
Net Cash Per Share	-11.45	-12.55	-12.83	-14.03	-14.72	-18.05
Filing Date Shares Outstanding	1,241	1,245	1,246	1,247	1,254	1,257
Total Common Shares Outstanding	1,242	1,246	1,246	1,247	1,254	1,254
Working Capital	5,576	7,169	4,805	3,206	3,162	4,599
Book Value Per Share	17.34	15.51	18.33	17.03	16.80	14.52
Tangible Book Value	-4,744	-8,932	-11,935	-15,968	-20,718	-23,032
Tangible Book Value Per Share	-3.82	-7.17	-9.58	-12.81	-16.52	-18.37
Land	-	561	561	562	404	404
Buildings	-	4,540	4,328	4,390	3,794	3,678
Machinery	-	2,282	2,216	1,990	1,759	1,697
Construction In Progress	-	501	661	719	1,057	856

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.